Interestingly, in a transgenic mouse model of Alzheimer’s disease (Ezra et al., 2016), HSA-treated mice showed increased myelin integrity and myelin basic protein (MBP) protein level. The gene discussed is ALB; the disease is early-onset autosomal dominant Alzheimer disease.